Ergoteles’s Ocugen OCGN Stock Holding History

Ergoteles’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-172,800	Closed	-$93.8K	–	584
2023 Q2	$93.8K	Sell	172,800 -1,344,001	-89%	-$862K	﹤0.01%	919
2023 Q1	$1.29M	Buy	+1,516,801	New	+$1.65M	0.05%	403

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Ergoteles's OCGN Position: Q3 2023 in Review

Ergoteles sold out of Ocugen (OCGN) in Q3 2023, closing a stake of 172,800 shares — an estimated $93.8K sold.

Ergoteles first reported a position in OCGN in Q1 2023 and held it in 2 quarters. The position peaked at $1.29M in Q1 2023. 78 funds tracked by Wall St. Rank hold OCGN as of Q3 2023.

Ergoteles reported no remaining Ocugen position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 172,800 Ocugen shares in Q3 2023, an estimated $93.8K.
Ergoteles first reported a position in Ocugen in Q1 2023 and held it in 2 quarters.
Ergoteles's Ocugen position peaked at $1.29M in Q1 2023.
78 funds tracked by Wall St. Rank held Ocugen as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.